Scleroderma Research Foundation

Mission

The mission of the Scleroderma Research Foundation is to fund and facilitate the most promising, highest quality research aimed at improved therapies and, ultimately, a cure for scleroderma.

Background

Founded by patient and activist Sharon Monsky in 1987, the Scleroderma Research Foundation (SRF) oversees a growing acclaimed national research program focused on extending the lifespan as well as improving quality of life for patients and has increased awareness of this life-threatening illness. Until a cure is found, the SRF will lead the way—working to help scleroderma patients everywhere live longer, fuller lives.